A detailed history of First Horizon Advisors, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 28 shares of EMBC stock, worth $561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 28 -0.0%
Holding current value
$561
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$12.35 - $19.33 $12 - $19
1 Added 3.7%
28 $0
Q1 2023

May 15, 2023

SELL
$23.07 - $32.77 $438 - $622
-19 Reduced 41.3%
27 $0
Q4 2022

Feb 10, 2023

SELL
$25.29 - $35.48 $2,048 - $2,873
-81 Reduced 63.78%
46 $1,000
Q3 2022

Nov 09, 2022

BUY
$24.0 - $33.42 $576 - $802
24 Added 23.3%
127 $3,000
Q2 2022

Aug 02, 2022

BUY
$24.78 - $33.36 $2,552 - $3,436
103 New
103 $2,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.16B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.